This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (2)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Quality of Care, Other  • Prognosis/ Outcomes  • Cancer Reconstruction of Head & Neck  • Alert me on articles by topic

Edgar A. Lueg, MD, FRCSC

Arch Otolaryngol Head Neck Surg. 2004;130:779-785.

Objective  To determine if patients undergoing microvascular reconstructive head and neck surgery (MRHNS) at a large integrated health maintenance organization can expect outcomes similar to some of the best or flagship centers in the United States.

Design  Outcomes (flap loss, mortality, length of stay), eligibility (recent consecutive US center experience), high-experience (100 cases), high-volume (26 cases per year), and flagship criteria were prospectively defined. A systematic MEDLINE search identified 17 eligible reports. Independent, blinded medical reviewers identified 5 centers (29%) as flagship centers.

Patients  The first 116 consecutive patients (average, 39 cases per year) who underwent MRHNS on this service.

Results  All 5 flagship centers are major academic health centers ranked in the top 18 "best head and neck hospitals" in the United States. Flap loss (1.7% vs 4.4% for flagship centers; range, 0.9%-8.8%) and mortality (2.6% vs 2.8% for flagship centers; range, 0.5%-6.3%) rates were not significantly different. Although lengths of stay in flagship centers were similar to each other and the literature (mean, 21.4 days; range, 20.1-22.5 days), our length of stay was significantly shorter (8.8 days, P<.001).

Conclusion  For high-experience and high-volume centers, patients undergoing MRHNS at a large integrated health maintenance organization can expect morbidity and mortality outcomes similar to flagship centers in the United States, with shorter hospitalizations.

From the Microvascular Reconstructive Head and Neck Surgery Service, Regional Head, Neck, and Skullbase Surgical Oncology Center, Southern California Permanente Medical Group, Los Angeles. The author has no relevant financial interest in this article.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Anterolateral Thigh Flap: Radial Forearm's "Big Brother" for Extensive Soft Tissue Head and Neck Defects
Lueg
Arch Otolaryngol Head Neck Surg 2004;130:813-818.
ABSTRACT | FULL TEXT